Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Biotechnology Department, University of Guilan, Rasht, Iran.
Inflammopharmacology. 2022 Oct;30(5):1479-1491. doi: 10.1007/s10787-022-01002-1. Epub 2022 May 30.
COVID-19 is one of the viral diseases that has caused many deaths and financial losses to humans. Using the available information, this virus appears to activate the host cell-death mechanism through Calpain activation. Calpain inhibition can stop its downstream cascade reactions that cause cell death. Given the main roles of Calpain in the entry and pathogenicity of the SARS-CoV-2, its inhibition can be effective in controlling the COVID-19. This review describes how the virus activates Calpain by altering calcium flow. When Calpain was activated, the virus can enter the target cell. Subsequently, many complications of the disease, such as inflammation, cytokine storm and pulmonary fibrosis, are caused by virus-activated Calpain function. Calpain inhibitors appear to be a potential drug to control the disease and prevent death from COVID-19.
COVID-19 是一种病毒性疾病,已导致许多人死亡和经济损失。根据现有信息,这种病毒似乎通过钙蛋白酶激活来激活宿主细胞死亡机制。钙蛋白酶抑制可以阻止其导致细胞死亡的下游级联反应。鉴于钙蛋白酶在 SARS-CoV-2 的进入和致病性中的主要作用,其抑制作用可能有助于控制 COVID-19。本综述描述了病毒如何通过改变钙流来激活钙蛋白酶。当钙蛋白酶被激活时,病毒可以进入靶细胞。随后,病毒激活的钙蛋白酶功能会导致疾病的许多并发症,如炎症、细胞因子风暴和肺纤维化。钙蛋白酶抑制剂似乎是一种控制疾病和预防 COVID-19 死亡的潜在药物。